Annual EBIT
$2.39 M
-$298.64 M-99.21%
December 31, 2023
Summary
- As of February 7, 2025, DVAX annual earnings before interest & taxes is $2.39 million, with the most recent change of -$298.64 million (-99.21%) on December 31, 2023.
- During the last 3 years, DVAX annual EBIT has risen by +$58.57 million (+104.25%).
- DVAX annual EBIT is now -99.21% below its all-time high of $301.03 million, reached on December 31, 2022.
Performance
DVAX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$21.23 M
+$4.91 M+30.11%
September 30, 2024
Summary
- As of February 7, 2025, DVAX quarterly earnings before interest & taxes is $21.23 million, with the most recent change of +$4.91 million (+30.11%) on September 30, 2024.
- Over the past year, DVAX quarterly EBIT has increased by +$5.67 million (+36.46%).
- DVAX quarterly EBIT is now -83.77% below its all-time high of $130.79 million, reached on June 30, 2022.
Performance
DVAX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$30.98 M
+$5.67 M+22.41%
September 30, 2024
Summary
- As of February 7, 2025, DVAX TTM earnings before interest & taxes is $30.98 million, with the most recent change of +$5.67 million (+22.41%) on September 30, 2024.
- Over the past year, DVAX TTM EBIT has dropped by -$38.35 million (-55.32%).
- DVAX TTM EBIT is now -90.70% below its all-time high of $333.10 million, reached on September 30, 2022.
Performance
DVAX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DVAX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.2% | +36.5% | -55.3% |
| 3 y3 years | +104.3% | +179.3% | +227.8% |
| 5 y5 years | +101.6% | +174.0% | +122.8% |
DVAX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.2% | at low | -83.8% | +195.2% | -90.7% | +1196.2% |
| 5 y | 5-year | -99.2% | +101.8% | -83.8% | +145.3% | -90.7% | +122.8% |
| alltime | all time | -99.2% | +101.6% | -83.8% | +145.3% | -90.7% | +120.6% |
Dynavax Technologies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.23 M(+30.1%) | $30.98 M(+22.4%) |
| Jun 2024 | - | $16.32 M(-261.7%) | $25.31 M(+73.2%) |
| Mar 2024 | - | -$10.09 M(-386.1%) | $14.61 M(+511.3%) |
| Dec 2023 | $2.39 M(-99.2%) | $3.53 M(-77.3%) | $2.39 M(-96.6%) |
| Sep 2023 | - | $15.55 M(+177.0%) | $69.33 M(-41.9%) |
| Jun 2023 | - | $5.62 M(-125.2%) | $119.28 M(-51.2%) |
| Mar 2023 | - | -$22.31 M(-131.7%) | $244.45 M(-18.9%) |
| Dec 2022 | $301.03 M(+239.4%) | $70.47 M(+7.6%) | $301.30 M(-9.5%) |
| Sep 2022 | - | $65.50 M(-49.9%) | $333.10 M(+38.3%) |
| Jun 2022 | - | $130.79 M(+278.7%) | $240.84 M(+104.7%) |
| Mar 2022 | - | $34.54 M(-66.2%) | $117.63 M(+32.6%) |
| Dec 2021 | $88.70 M(-257.9%) | $102.27 M(-482.2%) | $88.70 M(-466.0%) |
| Sep 2021 | - | -$26.75 M(-452.9%) | -$24.23 M(-306.8%) |
| Jun 2021 | - | $7.58 M(+35.3%) | $11.72 M(-127.4%) |
| Mar 2021 | - | $5.60 M(-152.6%) | -$42.71 M(-24.0%) |
| Dec 2020 | -$56.18 M(-58.6%) | -$10.66 M(-216.0%) | -$56.18 M(-27.4%) |
| Sep 2020 | - | $9.20 M(-119.6%) | -$77.41 M(-32.9%) |
| Jun 2020 | - | -$46.85 M(+495.7%) | -$115.28 M(+8.2%) |
| Mar 2020 | - | -$7.86 M(-75.3%) | -$106.55 M(-21.4%) |
| Dec 2019 | -$135.62 M(-9.3%) | -$31.89 M(+11.2%) | -$135.62 M(-3.8%) |
| Sep 2019 | - | -$28.68 M(-24.8%) | -$140.95 M(-6.1%) |
| Jun 2019 | - | -$38.12 M(+3.2%) | -$150.06 M(+0.9%) |
| Mar 2019 | - | -$36.94 M(-0.8%) | -$148.70 M(-0.6%) |
| Dec 2018 | -$149.56 M(+57.2%) | -$37.22 M(-1.5%) | -$149.56 M(+5.2%) |
| Sep 2018 | - | -$37.79 M(+2.8%) | -$142.12 M(+12.2%) |
| Jun 2018 | - | -$36.75 M(-2.8%) | -$126.71 M(+14.9%) |
| Mar 2018 | - | -$37.80 M(+27.0%) | -$110.28 M(+15.9%) |
| Dec 2017 | -$95.15 M(-15.4%) | -$29.77 M(+33.0%) | -$95.15 M(+10.1%) |
| Sep 2017 | - | -$22.39 M(+10.2%) | -$86.44 M(-12.6%) |
| Jun 2017 | - | -$20.32 M(-10.4%) | -$98.88 M(-8.3%) |
| Mar 2017 | - | -$22.67 M(+7.7%) | -$107.82 M(-4.1%) |
| Dec 2016 | -$112.44 M(+5.9%) | -$21.06 M(-39.6%) | -$112.44 M(-4.9%) |
| Sep 2016 | - | -$34.84 M(+19.1%) | -$118.25 M(+4.2%) |
| Jun 2016 | - | -$29.25 M(+7.2%) | -$113.47 M(+5.5%) |
| Mar 2016 | - | -$27.29 M(+1.6%) | -$107.55 M(+1.2%) |
| Dec 2015 | -$106.22 M(+17.1%) | -$26.86 M(-10.6%) | -$106.22 M(+5.0%) |
| Sep 2015 | - | -$30.06 M(+28.9%) | -$101.15 M(-0.0%) |
| Jun 2015 | - | -$23.33 M(-10.2%) | -$101.16 M(-1.5%) |
| Mar 2015 | - | -$25.97 M(+19.2%) | -$102.69 M(+13.2%) |
| Dec 2014 | -$90.69 M(+36.4%) | -$21.79 M(-27.6%) | -$90.69 M(+10.9%) |
| Sep 2014 | - | -$30.08 M(+21.0%) | -$81.81 M(+21.4%) |
| Jun 2014 | - | -$24.85 M(+77.9%) | -$67.38 M(+12.9%) |
| Mar 2014 | - | -$13.97 M(+8.2%) | -$59.66 M(-10.3%) |
| Dec 2013 | -$66.49 M | -$12.91 M(-17.5%) | -$66.49 M(-9.6%) |
| Sep 2013 | - | -$15.65 M(-8.7%) | -$73.54 M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$17.14 M(-17.6%) | -$75.09 M(+3.6%) |
| Mar 2013 | - | -$20.79 M(+4.2%) | -$72.47 M(+7.2%) |
| Dec 2012 | -$67.60 M(+44.9%) | -$19.96 M(+16.0%) | -$67.60 M(+31.4%) |
| Sep 2012 | - | -$17.20 M(+18.5%) | -$51.44 M(+4.9%) |
| Jun 2012 | - | -$14.52 M(-8.8%) | -$49.06 M(+9.8%) |
| Mar 2012 | - | -$15.92 M(+319.2%) | -$44.68 M(-4.3%) |
| Dec 2011 | -$46.64 M(-16.2%) | -$3.80 M(-74.4%) | -$46.69 M(-29.9%) |
| Sep 2011 | - | -$14.82 M(+46.0%) | -$66.58 M(+13.8%) |
| Jun 2011 | - | -$10.15 M(-43.4%) | -$58.51 M(-9.5%) |
| Mar 2011 | - | -$17.93 M(-24.3%) | -$64.63 M(+16.1%) |
| Dec 2010 | -$55.65 M(+268.2%) | -$23.68 M(+250.8%) | -$55.65 M(+27.7%) |
| Sep 2010 | - | -$6.75 M(-58.5%) | -$43.59 M(-8.3%) |
| Jun 2010 | - | -$16.27 M(+81.8%) | -$47.55 M(+67.4%) |
| Mar 2010 | - | -$8.95 M(-22.9%) | -$28.41 M(+88.0%) |
| Dec 2009 | -$15.12 M(-37.3%) | -$11.61 M(+8.4%) | -$15.12 M(+839.4%) |
| Sep 2009 | - | -$10.71 M(-473.6%) | -$1.61 M(-148.1%) |
| Jun 2009 | - | $2.87 M(-34.0%) | $3.35 M(-154.3%) |
| Mar 2009 | - | $4.34 M(+129.5%) | -$6.16 M(-74.5%) |
| Dec 2008 | -$24.12 M(-66.1%) | $1.89 M(-132.9%) | -$24.12 M(-39.7%) |
| Sep 2008 | - | -$5.76 M(-13.2%) | -$40.03 M(-25.1%) |
| Jun 2008 | - | -$6.63 M(-51.3%) | -$53.45 M(-22.1%) |
| Mar 2008 | - | -$13.62 M(-2.8%) | -$68.64 M(-3.5%) |
| Dec 2007 | -$71.09 M(+16.9%) | -$14.02 M(-26.9%) | -$71.09 M(-10.1%) |
| Sep 2007 | - | -$19.18 M(-12.1%) | -$79.07 M(+4.1%) |
| Jun 2007 | - | -$21.82 M(+35.7%) | -$75.99 M(+11.8%) |
| Mar 2007 | - | -$16.08 M(-26.9%) | -$67.97 M(+11.8%) |
| Dec 2006 | -$60.80 M(+170.4%) | -$21.99 M(+36.6%) | -$60.80 M(+25.9%) |
| Sep 2006 | - | -$16.10 M(+16.6%) | -$48.28 M(+18.1%) |
| Jun 2006 | - | -$13.81 M(+55.0%) | -$40.90 M(+13.3%) |
| Mar 2006 | - | -$8.91 M(-5.9%) | -$36.10 M(+60.5%) |
| Dec 2005 | -$22.49 M(+33.4%) | -$9.47 M(+8.7%) | -$22.49 M(+21.5%) |
| Sep 2005 | - | -$8.71 M(-3.3%) | -$18.52 M(+31.4%) |
| Jun 2005 | - | -$9.01 M(-291.6%) | -$14.09 M(+72.4%) |
| Mar 2005 | - | $4.70 M(-185.6%) | -$8.17 M(-51.5%) |
| Dec 2004 | -$16.86 M(-5.1%) | -$5.50 M(+28.2%) | -$16.86 M(-42.4%) |
| Sep 2004 | - | -$4.29 M(+38.4%) | -$29.25 M(+17.3%) |
| Jun 2004 | - | -$3.10 M(-22.3%) | -$24.94 M(+14.7%) |
| Mar 2004 | - | -$3.98 M(-77.7%) | -$21.75 M(-3.3%) |
| Dec 2003 | -$17.76 M(-4.8%) | -$17.88 M(<-9900.0%) | -$22.48 M(+388.8%) |
| Sep 2003 | - | $23.00 K(-76.0%) | -$4.60 M(-0.5%) |
| Jun 2003 | - | $96.00 K(-102.0%) | -$4.62 M(-2.0%) |
| Mar 2003 | - | -$4.72 M | -$4.72 M |
| Dec 2002 | -$18.66 M(-4.5%) | - | - |
| Dec 2001 | -$19.53 M(+66.7%) | - | - |
| Dec 2000 | -$11.72 M | - | - |
FAQ
- What is Dynavax Technologies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dynavax Technologies?
- What is Dynavax Technologies annual EBIT year-on-year change?
- What is Dynavax Technologies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dynavax Technologies?
- What is Dynavax Technologies quarterly EBIT year-on-year change?
- What is Dynavax Technologies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dynavax Technologies?
- What is Dynavax Technologies TTM EBIT year-on-year change?
What is Dynavax Technologies annual earnings before interest & taxes?
The current annual EBIT of DVAX is $2.39 M
What is the all time high annual EBIT for Dynavax Technologies?
Dynavax Technologies all-time high annual earnings before interest & taxes is $301.03 M
What is Dynavax Technologies annual EBIT year-on-year change?
Over the past year, DVAX annual earnings before interest & taxes has changed by -$298.64 M (-99.21%)
What is Dynavax Technologies quarterly earnings before interest & taxes?
The current quarterly EBIT of DVAX is $21.23 M
What is the all time high quarterly EBIT for Dynavax Technologies?
Dynavax Technologies all-time high quarterly earnings before interest & taxes is $130.79 M
What is Dynavax Technologies quarterly EBIT year-on-year change?
Over the past year, DVAX quarterly earnings before interest & taxes has changed by +$5.67 M (+36.46%)
What is Dynavax Technologies TTM earnings before interest & taxes?
The current TTM EBIT of DVAX is $30.98 M
What is the all time high TTM EBIT for Dynavax Technologies?
Dynavax Technologies all-time high TTM earnings before interest & taxes is $333.10 M
What is Dynavax Technologies TTM EBIT year-on-year change?
Over the past year, DVAX TTM earnings before interest & taxes has changed by -$38.35 M (-55.32%)